187 research outputs found
β4-ã¬ã©ã¯ããŒã¹è»¢ç§»é µçŽ -Iæ¬ æã«ããIgaè ççºçæ©æ§ã®è§£æ
é沢倧åŠåŠéç§åŠå®éšã»ã³ã¿ãŒÎ²4GalT-I KOããŠã¹ãèªç¶çºçããIgAè
çã®ç
æ
ã®é²è¡ãæããã«ããããã«,çåŸ2ã¶æ霢ãã12ã¶æ霢ã«ããã£ãŠ2ã¶æããšã«è€æ°å¹ã®ããŠã¹ã®è
èåçãäœæã,PASæè²ã«ãã糞çäœã®ç
å€é åã®åå®,PAMæè²ã«ãã糞çäœç¡¬åã®çšåºŠ,èå
å
ç«æè²ã«ããIgAãšC3ã®æ²ççšåºŠã«ã€ããŠå®éçãªè§£æãè¡ã£ããβ4GalT-I KOããŠã¹ã®IgAè
çç
å€ã¯,çåŸ2-3ã¶æ霢ã§ãã§ã«75%ã®ç³žçäœãåç¯æ§ç
å€ã瀺ã,12ã¶æ霢ã§ã¯25%ã®ç³žçäœãå
šç¯æ§ã®ç
å€ã«é²è¡ããã糞çäœç¡¬åãå幎霢ãŸã§ã¯çŽ20%ã®é åã,å幎霢ãã1幎霢ã§ã¯çŽ30%ã®é åã硬åç
å€ã瀺ããããŸã,IgAãšC3ã®æ²çãçåŸ3ã¶æ霢ããé¡èã«èŠãã,å 霢ãšå
±ã«æ²çã®çšåºŠãé²è¡ããã以äžã®ããšããβ4GalT-I KOããŠã¹ã¯,2-3ã¶æ霢ã®è¥å¹ŽããIgAè
çãçºçã,æ£è
ãšåãããã«ç³žçäœç
å€ãé²è¡ããããšãããã£ãããããŸã§ã®çµæãšä»å¹ŽåºŠã®çµæããŸãšããŠ,Am J Patholã«è«æãšããŠçºè¡šãããšå
±ã«,å¹³æ15幎4æã«åºé¡ããŠããç¹èš±ãIgAè
çã®æ²»çè¬ã®ã¹ã¯ãªãŒãã³ã°æ¹æ³ãã,å¹³æ18幎6æã«ç»é²ããããäžæ¹,β4GalT-II KOããŠã¹ã®ä¹³è
ºã®çºéç°åžžã«ã€ããŠã¯,ååš©ååŸã®ä¹³è
ºäžç®ã®å¢æ®ãææã«äœäžããŠããããšãèŠãã ã,ä¹³è
ºäžç®ã®å代å¹é€ç³»ãæš¹ç«ããããŸã,C57BL/6ã«æ»ã亀é
ããβ4GalT-II KOããŠã¹ã®äžé£ã®è¡ååŠç解æãã,ãã®ããŠã¹ã¯æ
åæ§ãäœãåŸåã«ãã,匷ãåºæ¿ã®èšé²ã«ã¯åé¡ããªãã,æ£ç¢ºãªç©ºéèšæ¶ã«åé¡ããã,éååŠç¿ã«ãé¡èãªé害ãããããšãæãããšãªã£ããè³ã§ã®æ©èœçç³éã®çºçŸã解æãããšãã,HNK-1ã®çºçŸãé¡èã«äœäžããŠããããšãããã,è¡ååŠçç°åžžã®äžéšã¯ãããåå ã§ããããšã瀺åããããç 究課é¡/é åçªå·:17046005, ç 究æé(幎床):2005 â 2006åºå
žïŒãβ4-ã¬ã©ã¯ããŒã¹è»¢ç§»é
µçŽ -Iæ¬ æã«ããIgaè
ççºçæ©æ§ã®è§£æãç 究ææå ±åæžã課é¡çªå·17046005ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-17046005/)ãå å·¥ããŠäœ
ORC4å€ç°ããŠã¹ãçšããåäœã¬ãã«ã§ã®çŽ°èåšæç 究
é沢倧åŠåŠéç§åŠå®éšã»ã³ã¿ãŒæšå¹ŽãŸã§ã«Origin Recognition Complex (ORC)ãæ§æãããµããŠãããã®1ã€ã§ããOrc4å€ç°ããŠã¹ãèç4.5æ¥ç®ä»¥éã«ã¢ãããŒã·ã¹ãèµ·ãããŠèŽæ»ãšãªãããšãæããã«ããããä»å¹ŽåºŠã¯ãã¢å€ç°èãã¬ã¹ãã¥ãŒããããã«loxPé
åã§æãã Orc4éºäŒåãå°å
¥ãããã©ã³ã¹ãžã§ããã¯(Tg)ããŠã¹ã®äœåºãè¡ã£ããOrc4 cDNAãloxPé
åã§æã¿ãããŒã«ãŒéºäŒåãšããŠInternal Ribosomal Entry Siteã®å¶åŸ¡äžã«GFPãçºçŸããããã«ããOrc4-GFPãã¯ã¿ãŒãäœè£œãããããã¢ãŒã¿ãŒã«ã¯CAGããã¢ãŒã¿ãŒãšPGKããã¢ãŒã¿ãŒãçšããããŸããHeLa现èããã³NIH3T3现èã«å°å
¥ããŠãGFPãçºçŸããããšã確èªããã次ã«ãPGKããã¢ãŒã¿ãŒå¶åŸ¡äžã«Orc4ãçºçŸãããã¯ã¿ãŒãçšããŠTgããŠã¹ã®äœåºãè©Šã¿ãçµæãçŸåšã®ãšãã2系統ã®TgããŠã¹ã®äœåºã«æåããããå
åšæ§Orc4éºäŒåã®ãã¢å€ç°ããŠã¹ãã¬ã¹ãã¥ãŒãããã®ã¯åŸãããªãã£ããå°å
¥éºäŒåç±æ¥ã®Orc4ã®çºçŸãæäœã®èåšå¥ã«èª¿ã¹ãçµæãè³ãå°è
žãçèãèžè
ºãèŸèã粟巣ã§ã¯åŒ·ãçºçŸã確èªã§ããããå¿èãèºãèèã§ã¯åŒ±ãçºçŸããèªãããããè
èã§ã¯ã»ãšãã©çºçŸãèªããããªãã£ããå
åšæ§ã®Orc4ã¯ãããã®èåšã«ãããŠã»ãŒåãã¬ãã«ã§çºçŸããŠããããšããããã¢å€ç°ããŠã¹ãçåã§ããªãã®ã¯å°å
¥éºäŒåã®çºçŸã匱ããããšèãããããããã§ãããã«TgããŠã¹ãäœæãããšå
±ã«ãåæèã§ã¯å°å
¥éºäŒåç±æ¥ã®Orc4ã®çºçŸãååã§ãããèæ§å¹¹çŽ°èãæš¹ç«ã§ããå¯èœæ§ãããã®ã§ããã¢å€ç°èã®å
éšçŽ°èå¡å¹é€ãè©Šã¿ãŠãããšããã§ãããOrc4ãã¢å€ç°èæ§å¹¹çŽ°èãæš¹ç«ã§ããã°ãCreã®çºçŸã«ããOrc4ã人çºçã«æ¬ æãããŠã现èåšæãDNAè€è£œã«ãããOrc4ã®åœ¹å²ã詳现ã«è§£æããããšãã§ãããç 究課é¡/é åçªå·:15657045, ç 究æé(幎床):2003 â 2004åºå
žïŒãORC4å€ç°ããŠã¹ãçšããåäœã¬ãã«ã§ã®çŽ°èåšæç 究ãç 究ææå ±åæžã課é¡çªå·15657045ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-15657045/)ãå å·¥ããŠäœ
ããã¯ã¢ãŠãããŠã¹ãçšããIL-1ã®å ç«åå¿åã³ã¹ãã¬ã¹å¿çã«ãããæ©èœè§£æ
é沢倧åŠå»è¬ä¿å¥ç 究åå»åŠç³» / æ±äº¬å€§åŠIL-1ã®æ©èœã®å
šäœåãæããã«ããç®çã§,IL-1α IL-1β,IL-1RaKOããŠã¹åã³IL-1α/βããã«KOããŠã¹ãäœè£œããŠ,å
ç«ç³»ãç¥çµç³»ã§ã®IL-1ã®æ©èœã«ã€ããŠç 究ãè¡ã,以äžã®ãããªçµæãåŸãã(1)IL-1βã¯ãã«ãã³ã«ããçºç±ãã°ã«ã³ã³ã«ãã³ã€ãã®åæ³ã«éèŠãªåœ¹å²ãæãããŠããã,IL-1αã¯ãããã®ççåå¿ã«ã¯ããŸãé¢äžããªãããšãæããã«ããã(2)ã¢ãããŒã·ã¹ãèªå°ããFasã¯,IL-1ã®äœçšãä»ããŠççåå¿ãèªå°ããããšãæããã«ããã(3)BALB/cèæ¯ã®IL-1RaKOããŠã¹ã¯,ããã®é¢ç¯ãªãŠããã«é¡äŒŒããèªå·±å
ç«æ§ã®é¢ç¯çãèªç¶çºçããããšãæãããšããã(4)HIV-1éºäŒåã®çºçŸã«IL-1ãšTNF-αãé¢äžããããšãæããã«ã,HIV-1çºçã«IL-1ãé¢äžããå¯èœæ§ã瀺åãããã5)ä»ã®ç 究宀ãšã®å
±åç 究ã«ãã,è³èè¡æã®ç¥çµçŽ°èã®ã¢ãããŒã·ã¹ãCaspase-2ãåŒãèµ·ããçæ®çŽ°èã®ã¢ãããŒã·ã¹ã«IL-1ãã¡ãã£ãšãŒã¿ãŒãšããŠäœçšããŠããããšãæãããšããã(6)IL-1βã¯T现èäŸåæ§ã®æäœç£çã«éèŠãªåããããŠããããšãæããã«ãããIL-1βã¯T现èäžã®CD40ãªã¬ã³ããšOX40ã®çºçŸãå¶åŸ¡ããããšã«ãã£ãŠ,æåæ瀺现èã«ããT现èã®ãã©ã€ãã³ã°ãèªå°ããŠããããšã瀺åããããäžæ¹,IL-αã¯æäœç£çã«ã¯é¢äžããªãããšãæããã«ãããã(7)IL-1αã¯æ¥è§Šéæçåå¿ã®èªå°ã«éèŠãªåœ¹å²ãæãããŠãã,ç¹ã«,æäœæã«ãããŠæåç¹ç°çãªT现èã®å¢æ®ãå¶åŸ¡ããŠããããšãæãããšãããäžæ¹,IL-1βã¯ãã®åå¿ã«ã¯é¢äžããªãããšãããã£ãã(8)HTLV-1ã®ãã©ã³ã¹ãžã§ããã¯ãã³ã©ãŒã²ã³èªå°é¢ç¯çã®ã¢ãã«ããŠã¹ã«ãããŠ,IL-1ãæ¬ æããããš,é¢ç¯çã®çºçãæå¶ãããããšãæããã«ãããIL-1 α, IL-1 β, IL-Ira KO and IL-1 α/β double KO mice were generated to elucidate pleiotropic function of IL-1 in an animal body, and roles of IL-1 in immune and stress responses were clarified as described below.(1) IL-1 β , but not IL-1 α, is crucial in terpentine-induced fever development and glucocorticoid secretion.(2) Inflammation induced by apoptosis inducer Fas ligand is mediated by IL-1 β which is released by caspase 1 independent mechanism.(3) Chronic inflammatory arthropathy resembling rheumatoid arthritis is spontaneously developed in IL-Ira KO mice on a BALB/c background.(4) LPS-induced HIV-1 expression in transgenic mice is mediated by TNF α and IL-1.(5) In collaboration with other laboratories, apoptosis in neural cells caused by ischaemia and apoptosis in germ cells caused by loss of ataxia telangiectasia-mutated (Atm) gene function are mediated by IL-1β.(6) T cell-dependent antibody production is regulated by IL-1 β, but not by IL-1 α, through induction of CD40L and OX40 on T cells.(7) IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity.(8) Suppression of autoimmune arthritis in IL-1 KO mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells.In support with the Grant-in-Aid for Scientific Research, various roles of IL-1 in fever development, stress response, antibody production, contact hypersensitivity, rheumatoid arthritis development and apoptosis of neural cells and germ cells were elucidated. These results and our IL-1 genes KO mice could be very useful to understand the mechanism of IL-1-mediated human diseases and to develop medical treatment for them.ç 究課é¡/é åçªå·:10670298, ç 究æé(幎床):1998 â 2000åºå
žïŒç 究課é¡ãããã¯ã¢ãŠãããŠã¹ãçšããIL-1ã®å
ç«åå¿åã³ã¹ãã¬ã¹å¿çã«ãããæ©èœè§£æã課é¡çªå·10670298ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒ ïŒhttps://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-10670298/106702982001kenkyu_seika_hokoku_gaiyo/ïŒãå å·¥ããŠäœ
èªå·±å ç«çŸæ£ã«ãããã¢ã¹ãã©ã®ã³ãšã³ããããããŒãŒã«ããå ç«èšæ¶ã®èª¿ç¯
é沢倧åŠåŠéç§åŠå®éšã»ã³ã¿ãŒã¢ã¹ãã©ã®ã³ãšã³ããããããŒãŒ(AEP)ã¯ãAsnã®Cæ«ç«¯åŽã§åæããã·ã¹ãã€ã³ãããã¢ãŒãŒã§ãããåŸæãšã³ããœãŒã ãããªãœãœãŒã ã«å±åšãããæè¿ãAEPã¯å€æ¥æåãèªå·±æå(ããšãªã³å¡©åºæ§ã¿ã³ãã¯è³ª:MBP)ã®ããã»ãã·ã³ã°ã®åæéçšãæ
ãããšã瀺åããå ±åãçžæ¬¡ãã ããããããããã®å ±åã¯AEPé»å®³å€ãçšããin vitroã®å®éšç³»ã§ãã£ãã®ã§ãAEP KOããŠã¹ãçšããŠãæåã®ããã»ãã·ã³ã°ãšæåæ瀺䞊ã³ã«å
ç«å¯å®¹ã®æç«ãšç Žç¶»ã«ãããAEPã®åœ¹å²ãæããã«ããããšãæ¬ç 究ã®ç®çãšãããæ¬å¹ŽåºŠã¯ãMBPãããããçšããå®éšçèªå·±å
ç«æ§è³èé«ç(EAE)çºçã«ãããAEPã®åœ¹å²ãäžå¿ã«ç 究ãé²ãããEAEã¯MHCæææ§ã§ããã®ã§,ãŸãEAEæåæ§ã®SJL系統ãšã®äº€é
ã«ããH-2^sããã¢ã«æã€EAEæåæ§ã®AEP KOããŠã¹ãäœåºãããã€ãã«AEPã®åæç¹ãå«ãMBP_ãããããçšããŠãAEP KOããŠã¹ãšã³ã³ãããŒã«ããŠã¹ã§EAEã®çºçãæ¯èŒããããçºççãããŒã¯ã¹ã³ã¢ãçºçæ¥æ°ã«ææãªå·®ã¯èªããããªãã£ããMBP_ããããã¯cryptic-dominantãªãšãããŒããäžå€®ã«æã€ãã䞡端ã«ã¯sub-dominantãªãšãããŒããå«ãããšãšãã«ããã·ã³Gã®åæç¹ãå«ãã§ããã®ã§ãçŸåšåã
ã®ãšãããŒãã ããæã€ããããã§EAEçºçãæ¯èŒããŠããããªããããŠã¹ã§ã¯èžè
ºäžŠã³ã«æ«æ¢¢ã®B现èã«ãããŠãAEPãšã«ããã·ã³Gã¯äž¡æ¹ãšãçºçŸããŠããããšãæããã«ãããäžæ¹ãAEP KOããŠã¹ã¯ãå 霢ãšå
±ã«èŸèãç°åžžã«è¥å€§ããããšãããã£ããèµ€èŸéãšçœèŸéã®å¢çãæ¿Ÿèæ§é ã圢æãããããªã³ãçã®æ¯çãåå以äžãšãªããæªæçãªåçç³»ãé¡ç²çç³»ã®çŽ°èãç°åžžã«å¢å ããŠãããæåæ瀺ãšã©ã®ããã«ç¹ãããã¯äžæã§ããããããã®çŸæ£ãšã®é¢é£ã暡玢ããªããåå 解æãé²ããŠãããç 究課é¡/é åçªå·:16043221, ç 究æé(幎床):2004åºå
žïŒãèªå·±å
ç«çŸæ£ã«ãããã¢ã¹ãã©ã®ã³ãšã³ããããããŒãŒã«ããå
ç«èšæ¶ã®èª¿ç¯ãç 究ææå ±åæžã課é¡çªå·16043221ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-16043221/)ãå å·¥ããŠäœ
ããã¯ã¢ãŠãããŠã¹ãçšããã¬ã©ã¯ããŒã¹è»¢ç§»é µçŽ éºäŒå矀ã®åœ¹å²åæ ã®è§£æ
é沢倧åŠåŠéç§åŠå®éšã»ã³ã¿ãŒçŽ°èã®å¢æ®ãšååã«ã¯çŽ°èéã®çžäºäœçšãéèŠã§ãã,现èè¡šé¢ã®ç³éãä»ããçžäºäœçšã¯ãã®äžã§ãéèŠãªæ©æ§ã®äžã€ã§ãããæã
ã¯Î²-1,4-ã¬ã©ã¯ããŒã¹è»¢ç§»é
µçŽ -I(β4GalT-I)éºäŒåKOããŠã¹ãäœæããŠ,çäœå
ã§ã®ã¬ã©ã¯ããŒã¹ç³éã®åœ¹å²ã解æããŠãããããã,æè¿Î²4GalTã7ã€ã®éºäŒåãããªããã¡ããªãŒã圢æããŠããããšãããã,β4GalTéºäŒå矀ã«åœ¹å²åæ
ãããããšãããã£ãŠãããããã§,β4GalT-I KOããŠã¹ã®ç³éæ§é ã詳现ã«è§£æããŠ,β1,4-çµåã®Galãå®éããç³éçåæã«ããã现èçš®ããšã®Î²4GalT-IéºäŒåã®å¯äžãæ€èšããã次ã«ãβ4GalTãçåæã«é¢äžããããšãç¥ãããŠããã»ã¬ã¯ãã³ã®ãªã¬ã³ãç³éã«ã€ããŠè§£æãããã®çåæã«ãããβ4GalT-Iã®å¯äžãæ€èšãããããã«ãã»ã¬ã¯ãã³ãé¢äžããççåå¿ã«ã€ããŠãβ4GalT-I KOããŠã¹ã®å¿çæ§ã解æããβ4GalT-IéºäŒåã®æ¬ æãççåå¿ã«äžãã圱é¿ãæããã«ããããŸããç®èåµå·æ²»çéçšã«ãããβ4GalT-IéºäŒåæ¬ æã®åœ±é¿ã解æããã以äžã®çµæãβ4GalT-Iã¯ã»ã¬ã¯ãã³ã®ãªã¬ã³ãç³éã®çåæã«éèŠãªåœ¹å²ãæ
ã£ãŠãããβ4GalT-I KOããŠã¹ã§ã¯ããã®æ¬ æã®ããã«ççåå¿ã®æžåŒ±ãç®èåµå·æ²»çéçšã®é
延ãçãããšèããããã以äžã®è§£æã¯ãã¹ãŠäº€éç³»ã®Î²4GalT-I KOããŠã¹ãçšããŠè¡ã£ãããäžæ¹ãè¿äº€ç³»ã®Î²4GalT-I KOããŠã¹ã¯èçåŸæã«èŽæ»ãšãªãããšãæããã«ãããèŽæ»ãšãªãæ°æ¥åããèä»ããã¯ãããèç€ã®æé·é
延ãé¡èã«èªããããèç€ã®ç°åžžãèŽæ»ã®åå ã§ããããšã瀺åãããããã®ããã«ããŠã¹ã®éºäŒçèæ¯ã«ããèŽæ»æ§ãå€åããçç±ãšããŠãä»ã®Î²4GalTéºäŒå矀ã«ããçžè£ãèããããã®ã§ãä»ã®Î²4GalTéºäŒåã®KOããŠã¹ãäœè£œããŠäž¡è
ã®åœ¹å²åæ
ã®è§£æãçŸåšé²ããŠãããCell-to-cell, interactions are important for cell growth and differentiation. The interaction through cell surface carbohydrates is one of indispensable mechanisms among them. We have been studying on the role of carbohydrates in vivo by generating a gene knockout mouse deficient in β-1.4-galactosyhransferase-I(β4GalT-I). β4GalTs are recently found to form the gene family consisting of 7 genes, which have their own roles.We analyzed carbohydrate structures of β4GalT-I KO mice in detail. Contribution of β4GalT-I gene to the biosynthesis of carbohydrates of various cell types was estimated by measuring Gal residues in the β1,4-linkage. Next, carbohydrate ligands of selectins, which are known to be synthesized by β4GalTs and other glycosyltransferases, were analyzed in β4GalT-I KO mice. Contribution of β4GalT-I gene to their biosynthesis was also estimated. Furthermore, Inflammatory responses of β4GalT-I KO mice and the effect of β4GalT-I deficiency were examined. In addition, the effect of β4GalT-I deficiency on skin wound healing was examined. Our results indicated that β4GalT-I plays an important role in the biosynthesis of carbohydrate ligands of selectins and their deficiency results in reduction of inflammatory responses and delayed wound healing in β4GalT-I KO mice.While these results were obtained using β4GalT-I KO mice on mixed genetic backgrounds, we found β4GalT-I KO mice on inbred background to be lethal during late embryogenesis. Since growth retardation of the placenta rather than the embryo was remarkable several days before its death, the defect of placenta was suggested to be a cause of the embryonic lethality. Since the reason of changeable lethality depending on genetic background might be a compensatory activity by other β4GalTs, gene knockout mice deficient in another β4GalT gene were generated. Studies on elucidating the role of these p4GalT genes are in progress.ç 究課é¡/é åçªå·:13480280, ç 究æé(幎床):2001 â 2003åºå
žïŒãããã¯ã¢ãŠãããŠã¹ãçšããã¬ã©ã¯ããŒã¹è»¢ç§»é
µçŽ éºäŒå矀ã®åœ¹å²åæ
ã®è§£æãç 究ææå ±åæžã課é¡çªå·13480280ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/report/KAKENHI-PROJECT-13480280/134802802003kenkyu_seika_hokoku_gaiyo/)ãå å·¥ããŠäœ
ç³è»¢ç§»é µçŽ éºäŒåæ¬ æããŠã¹ãçšããçºçã»è»¢ç§»ã«ãããç³éæ©èœã®è§£æ
é沢倧åŠå»è¬ä¿å¥ç 究åå»åŠç³»ç现èã®è¡šé¢ã«ã¯ç¹åŸŽçãªç³éæ§é ãèŠãåºãããŠãã,ãããã现èã®ããåã浞最ã»è»¢ç§»ã«é¢é£ããŠãããšèšãããŠãããå®é,ç现èç¹ç°çãªè
«çæåã®å€ãã¯ç³éæåã§ãã,è
«çããŒã«ãŒãšããŠèšºæã«ãå©çšãããŠãããããã,ä»ãŸã§ã®ç 究ã¯ãããã®ç³éæ§é ãšçŽ°èã®ããåããã®æªæ§åºŠãšã®çžé¢é¢ä¿ã調ã¹ããã®ãã»ãšãã©ã§ãã,ç³éãç现èã®æ§è³ªã«ã©ã®ãããªåœ±é¿ãäžããŠãããã¯ããããã£ãŠããªããæ¬ç 究ã§ã¯,æã
ãäœè£œããβ-1,4-ã¬ã©ã¯ããŒã¹è»¢ç§»é
µçŽ -I(GalT-I)KOããŠã¹ãçšããŠ,ã«ã€ã¹(Le)æåãªã©ã®è
«çç³éæåã®æ§é ã®å€åã,现èã®ããåãšåœ¢æãããè
«ç现èã®å¢æ®ã浞最,転移ãªã©ã®æ§è³ªã«äžãã圱é¿ãæããã«ããããã®ããã«,æ¬å¹ŽåºŠã¯ãã®ããŠã¹ã«ãããåºå¹¹ç³éæ§é ã®è§£æãè¡ããšå
±ã«,ååŠçºããå€ã«ããèªçºè
«çããåŸãè
«ç现èæ ªã®åé¢ãè¡ã,GalT-IéºäŒåãåå°å
¥ããŠåæ¹ã®çŽ°èæ ªã®æ§è³ªã®è§£æãè¡ã£ããGalT-I KOããŠã¹ã«ãããè¡æž
ç³ã¿ã³ãã¯ã®åºå¹¹ç³éæ§é ã調ã¹ããšãã,GalT-1ãåæã«é¢äžãã2åç³éã®åæéãäœäžããŠããããšã«å ã,éåžžã¯æ®ã©åæãããŠããªã1åç³éã®åæéãé¡èã«å¢å ããŠãããããã§,GalT-IKOããŠã¹ã®ç®èã«ååŠçºçå€ãå¡åžããŠåŸãè
«çãã现èãåé¢ã»æ ªåã,ãã®æ§ç¶ã解æãããçºçå€å¡åžã«ããèªçºããGalT-IKOã®è
«çã«æ¯ã¹,察ç
§çŸ€ã§ã¯å¢æ®ã®æ©ãè
«çãå€ãåŸåãèŠããããããããªããè
«çãã现èãæ ªåããŠæ¯èŒå¯žããš,å¢æ®é床ã®å·®ã¯ãããæ ªéã®æ§è³ªã®å€æ§æ§ã«è² ããšããã倧ããã£ããããã§GalT-IKOããŠã¹ç±æ¥è
«ç现èæ ªã«GalT-1éºäŒåãå°å
¥ããŠæ¯èŒãããšãã,现èæ¥çèœã«å·®ã¯èŠãããªãã£ãã,in vitroã§ã®migration掻æ§ãinvasion掻æ§ã¯å°å
¥GalT-1éºäŒåã®çºçŸéãšçžé¢ãã掻æ§äœäžã芳å¯ããããä»åŸã¯in vivoã§ã®æµžæœ€ã転移èœã解æããŠ,ã©ã®ãããªç³éæ§é ããã现èã®æ§è³ªã«åœ±é¿ãäžããŠããããæããã«ããŠããäºå®ã§ãããç 究課é¡/é åçªå·:13216038, ç 究æé(幎床):2001åºå
žïŒãç³è»¢ç§»é
µçŽ éºäŒåæ¬ æããŠã¹ãçšããçºçã»è»¢ç§»ã«ãããç³éæ©èœã®è§£æãç 究ææå ±åæžã課é¡çªå·13216038ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-13216038/)ãå å·¥ããŠäœ
The germline: its developmental cycle and epigenome network
é沢倧åŠåŠéç§åŠå®éšã»ã³ã¿ãŒHP1Yæ¬ æããŠã¹ãçšãã解æãã,HP1γã¯æžæ°åè£æã®çžåæè²äœã®å¯Ÿå(Takada,Naruse,et al.,Development,2011)åã³PGCã®å¢æ®(Abe et al.,Biol Reprod,2011)ã«éèŠãªåœ¹å²ãæãããŠããããšãæããã«ããŠè«æãšããŠçºè¡šããã24幎床ã¯è»¢åæå¶æ§ãã¹ãã³ä¿®é£ŸH3K27me3ã®è±ã¡ãã«åé
µçŽ Jmjd3ã®è§£æãäžå¿ã«é²ãããJmjd3æ¬ æããŠã¹ã¯åºççŽåŸã«èŽæ»ãšãªã,äœè»žåœ¢æã«ç°åžžãèªãããããäœè»žåœ¢æã«éèŠãªåœ¹å²ãæ
ã£ãŠããHoxéºäŒå矀ãäžå¿ã«,å®éRT-PCRãã¯ãããã³æ²éæ³ãçšããŠ,Jmjd3ãäœè»žåœ¢æãå¶åŸ¡ããã¡ã«ããºã ã解æããããã®çµæ,Jmjd3ã¯HoxéºäŒå矀ã«çµåã,転åæå¶ããŒã¯ã®H3K27me3ãè±ã¡ãã«åããããšã«ãã,äžéšã®HoxéºäŒå矀ã®çºçŸããã®çºçŸéå§æã«ãããŠå¶åŸ¡ããŠããããšãæããã«ãã(è«ææçš¿äž)ãäžæ¹,Jmjd3æ¬ æããŠã¹ã®èç€ãé圢æãçããããšãããã£ããJmjd3æ¬ æèç€ã§ã¯èç€ç¹ç°çã€ã³ããªã³ãéºäŒå矀ã®çºçŸãç°åžžã«ãªã£ãŠãã,äžéšã®ã€ã³ããªã³ãéºäŒå矀ã®çºçŸã¯,ãã¯ãJmjd3ã«ããH3K27me3ã®è±ã¡ãã«åã§å¶åŸ¡ãããŠããããšãæããã«ãã(è«ææºåäž)ãJmjd3æ¬ æããŠã¹ã¯åºççŽåŸã«èŽæ»ã§ãã£ãã®ã§,çåŸã®çæ®çŽ°èã«ã€ããŠè§£æããããšãã§ããªãã£ããããã§Jmjd3-floxããŠã¹ãšéæ§çæ®çŽ°èã§ç¹ç°çã«CreãçºçŸããTNAP-CreããŠã¹ãšã亀é
ããŠ,éæ§çæ®çŽ°èç¹ç°çJmjd3æ¬ æããŠã¹ãäœè£œããã,çæ®çŽ°èã®ç°åžžã¯èŠ³å¯ã§ããªãã£ããç 究課é¡/é åçªå·:23013012, ç 究æé(幎床):2011 â 201
The germline: its developmental cycle and epigenome network
éæ²¢å€§åŠ åŠéç§åŠå®éšã»ã³ã¿ãŒ(1)HP1γå€ç°ããŠã¹ã®å§åçæ®çŽ°è(PGC)ã®è§£æHP1γã¯ã¡ãã«åãã¹ãã³(H3K9me)ã«çµåãããšããžã§ããã£ãã¯å¶åŸ¡å åã®äžã€ã§ããã22幎床ã¯HP1γå€ç°ããŠã¹ã«ãããŠPGCã®æ°ãå°ãªãåå ãããã«è¿œåãããPGCã®éåœæ±ºå®ãçæ®éèµ·ãžã®ç§»å,现èæ»,ãã¹ãã³ä¿®é£Ÿã«ç°åžžã¯ãªã,PGCã®å¢æ®ã«åé¡ãããããšãæããã«ãããE12.5ã®å¢æ®æã®HP1γå€ç°PGCã¯BrdUã®å蟌ã¿ãææã«äœäžããŠãã,ãããŒãµã€ãã¡ããªãŒã®è§£æãããHP1γå€ç°PGCã¯G1æã«éç©ããŠãã,Sæãžã®ç§»è¡ãæå¶ãããŠãããæ§ã
ãªçŽ°èåšæå¶åŸ¡å åã解æãããšãã,HP1γå€ç°èã§ã¯ãµã€ã¯ãªã³äŸåæ§ãããŒãŒé»å®³æŽ»æ§ãæã€p21(Cip)ãçºçŸããPGCã®å²åãå¢å ã,p21ã®éç©ãG1/Sæ移è¡ã®é
延ãåŒãèµ·ãããŠããå¯èœæ§ã瀺åããããããããªããE11.5ã®éçåPGCãšHP1γå€ç°PGCãšã®ãã€ã¯ãã¢ã¬ã€è§£æã§ã¯,ä»ã®çŽ°èåšæå¶åŸ¡éºäŒåã®çºçŸã«ææãªéãã¯èŠãããªãã£ãã以äžã®çµæããŸãšããŠè«æãæçš¿ãããšãã,ããã€ãã®è¿œå å®éšãæ±ãããããç¹ã«PGCã®æ°ã®æžå°ãæåã«èªããããE7.25ã®HP1γå€ç°PGCã§ãBrdUã®å蟌ã¿ãäœäžããŠããããš,PGCã®in vitroå¹é€ç³»ã§ãHP1γå€ç°PGCã®å¢æ®ãäœäžããŠããããšãæããã«ããŠåæçš¿ãè¡ã£ãã(2)ãã¹ãã³è±ã¡ãã«åé
µçŽ ã®æ¬ æããŠã¹ã®äœè£œãã¹ãã³ã®ã¡ãã«åã¯ãšããžã§ããã£ãã¯ãªå¶åŸ¡ã®äžå¿çãªåœ¹å²ãæãããŠããã,è±ã¡ãã«åé
µçŽ ã¯ãŸã äžæãªç¹ãå€ããäºã€ã®è±ã¡ãã«åé
µçŽ éºäŒåã«ã€ããŠããããfloxããŠã¹ãäœè£œã,TNAPCreããŠã¹ãšäº€é
ããããšã«ãã,çæ®çŽ°èç¹ç°çã«æ¬ æããããŠã¹ãäœè£œããŠããããããã®çæ®çŽ°èã®è§£æã¯,次ã®2幎éã®æ¬ç¹å®é åã®ç 究ããŒããšããŠè§£æãé²ããäºå®ã§ãããç 究課é¡/é åçªå·:21028007, ç 究æé(幎床):2009 â 201
ã¬ã©ã¯ããŒã¹è»¢ç§»é µçŽ éºäŒåããã¯ã¢ãŠãããŠã¹ãçšããç³éæ©èœã®è§£æ
é沢倧åŠå»åŠéšäº€éç³»(129/Sv x C57BL/6)ã®GalT-I KOããŠã¹ã¯,äºæ³ã«åããŠçºçéçšã«åé¡ã¯ãªãæ£åžžã«çºçãããããã§GalT-Iæ¬ æã®åœ±é¿ãæŽã«è§£æããããã«,è¿äº€ç³»ã®ããŠã¹ã«8äžä»£æ»ã亀é
ããGalT-I KOããŠã¹ãäœè£œãã,ãããšé©ããããšã«,C57BL/6èæ¯ã®KOããŠã¹ã¯åºçæã«100%æ»äº¡ã,BALB/cèæ¯ã®KOããŠã¹ã¯èçåŸæã«èŽæ»ãšãªãããšãæãããšãªã£ããBALB/cèæ¯ã®KOèä»ã®æ»äº¡ææãæããã«ããããã«,èä»ãçµæçã«åãåºããŠè§£æãããšãã,èç14.5æ¥ãã16.5æ¥ã®éã«æ»äº¡ããããšãæãããšãªã£ããèä»ãšèç€ã®ééã枬å®ããŠåè
¹ã®ã³ã³ãããŒã«ãšæ¯èŒãããšãã,KOèä»ã¯èç14.5æ¥ã§ã¯è¥å¹²å°ãã,ãã®åŸæé·ãæ¢ãŸã£ãŠ16.5æ¥ãŸã§ã«æ»äº¡ãããããã«å¯ŸããŠèç€ã¯èç12.5æ¥ã§ãã§ã«å°ããåŸåãèŠãã,14.5æ¥ã§ã¯ææã«çºéãé
延ããŠãããèç€ã®çµç¹åçã解æãããšãã,æ¯äœãšèä»ãç¹ã海綿ç¶æ é€èå±€ãèã,èä»åŽã®è¿·å®®å±€ã®è¡ç®¡åœ¢æãäžå
šã§,è¡æµãèããæžå°ããŠãããèä»çµç¹ã®è§£æããŸã çµäºããŠããªãã,èç€ã®æèŠããBALB/cèæ¯ã®GalT-I KOããŠã¹ã¯èç€ã®çºéã«ç°åžžãããããã«,èçåŸæã«èŽæ»ãšãªãããšã瀺åããããC57BL/6èæ¯ã®èä»ã¯èç17.5æ¥ããææã«æé·ã®é
延ãèªããã,åºçæã®äœéãã³ã³ãããŒã«ã®70%ãããªã,æªçå
ã®ç¶æ
ã§åºçããããšãããã£ããæ°çå
ã調ã¹ããšèºèãå
šãèšããŸãã«æ»äº¡ããŠããã®ã§,çŽæ¥ã®æ»å ã¯æªçå
ã§åºçããããã«èºåŒåžã«ç§»è¡ã§ããªãããšã§ãããšèããããããããåºçåã®èç€ã調ã¹ãŠã¿ããšçšåºŠã¯è»œããã®ã®BALB/cèæ¯ã®GalT-I KOããŠã¹ãšåãç°åžžãèªããããã®ã§,ãã®ããŠã¹ãèç€ã®çºéç°åžžãèä»ã®æé·é
延ã®åå ãšèããããã以äžã®çµæ,GalT-Iãåæããç³éã¯èç€ã®æé·ã«å¿
é ã§ãã,ãã®æ©èœã¯ããŠã¹ã®éºäŒçèæ¯ã«ããéåžžã«åŒ·ã圱é¿ãåããããšãæãããšãªã£ããç 究課é¡/é åçªå·:12033202, ç 究æé(幎床):2000åºå
žïŒç 究課é¡ãã¬ã©ã¯ããŒã¹è»¢ç§»é
µçŽ éºäŒåããã¯ã¢ãŠãããŠã¹ãçšããç³éæ©èœã®è§£æã課é¡çªå·12033202ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒ ïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-12033202/ïŒãå å·¥ããŠäœ
æ¹è¯éºäŒåãã©ããæ³ã«ããæ°èŠçºçå¶åŸ¡éºäŒåã®åé¢ãšæ©èœè§£æ
é沢倧åŠåŠéç§åŠå®éšã»ã³ã¿ãŒåºä¹³é¡ã®çºçã·ã¹ãã ãç解ããããã«ãåè
žé¥å
¥ã»äžèè圢ææã«åã転åå åã®äžæµã«ååšããçºçå¶åŸ¡éºäŒåããæ¹è¯éºäŒåãã©ããæ³ã«ãã£ãŠåé¢ããŠãæ©èœã解æããããšãæ¬ç 究ã®ç®çã§ãããBrachyuryãHNF-3βãPax1ã«ããçºçŸèª¿ç¯ããããšèããããéºäŒåããã©ããããES现èã4ã¯ããŒã³åŸããããããããŸã§ã«ãHeterochromatin Protein(HP)1γãšWilms\u27 tumor 1-associating protein (WTAP)ããã©ããããã¯ããŒã³ããçæ®ç³»åãã¡ã©ããŠã¹ãåŸãããéºäŒåå€ç°ããŠã¹ã®äœæã«æåããããããå士ã®äº€é
ãè¡ã£ããšãããWTAPãã¢å€ç°ããŠã¹ã¯èçæã«å®å
šã«èŽæ»ã§ããããšãHP1γãã¢å€ç°ããŠã¹ãããäžéšçåãããã®ã®ã»ãšãã©ãèçæã«èŽæ»ã§ããããšãããããæ¹è¯éºäŒåãã©ããæ³ã«ããçºçã«å¿
é ã®éºäŒåãåé¢ãããŠããããšãããã£ãããã©ãããã¯ã¿ãŒå
ã®çºçŸããŒã«ãŒã§ããLacZãçšããŠãããããã®èã«ãããçºçŸãã¿ãŒã³ã調ã¹ãçµæãHP1γã¯å粟åŸ5.5æ¥ãããWTAPã¯å粟åŸ3.5æ¥ããçºçŸãæ€åºã§ããäž¡éºäŒåãšãçºçã®éåžžã«æ©ãææããçºçŸãèªãããããçŸåšãæ»äº¡ææã®åå®ãšæ»äº¡åå ã®è§£æãè¡ã£ãŠããããäž¡éºäŒåãšãçºçåæã«éèŠãªåœ¹å²ãæ
ã£ãŠããå¯èœæ§ãèãããããä»åŸãçºçéçšã§ã®çºçŸãã¿ãŒã³ã詳现ã«æãã«ããŠãã¹ã¯ãªãŒãã³ã°ã«çšããBrachyuryãHNF-3βãPax1ã«ãã£ãŠããã®çºçŸãå¶åŸ¡ãããŠãããã©ãããæãã«ããŠè¡ãäºå®ã§ãããç 究課é¡/é åçªå·:14034218, ç 究æé(幎床):2002 â 2003åºå
žïŒãæ¹è¯éºäŒåãã©ããæ³ã«ããæ°èŠçºçå¶åŸ¡éºäŒåã®åé¢ãšæ©èœè§£æãç 究ææå ±åæžã課é¡çªå·14034218ïŒKAKENïŒç§åŠç 究費å©æäºæ¥ããŒã¿ããŒã¹ïŒåœç«æ
å ±åŠç 究æïŒïŒïŒhttps://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-14034218/)ãå å·¥ããŠäœ
- âŠ